Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Hack

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Environmental Epigenetics|March 2, 2018
Epigenetic mechanisms involved in the effects of stress exposure: focus on 5-hydroxymethylcytosineLaura M Hack, Alec L W Dick, Nadine Provençal
Drugs in Context|February 16, 2018
Practical outpatient pharmacotherapy for alcohol use disorderYoungjung Kim, Laura M Hack, Elizabeth S Ahn, et al.
A&A Practice|August 11, 2022
Anesthetic-Induced Intraoperative Dream Associated With Remission of a Psychiatric Disorder: A Case ReportHarrison S Chow, Laura M Hack, Makoto Kawai, et al.
Journal of Affective Disorders|April 4, 2025
Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trialTheresa R Lii, Josephine R Flohr, Robin L Okada, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Opioids Diminish the Placebo Antidepressant Response: A Post Hoc Analysis of a Randomized Controlled Ketamine TrialTheresa R Lii, Josephine R Flohr, Robin L Okada, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 24, 2020
Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trialAdina S Fischer, Bailey Holt-Gosselin, Scott L Fleming, et al.
Nature. Mental Health|November 10, 2025
A stratified precision medicine trial targeting α<sub>2A</sub>-adrenergic receptor agonism as a treatment for the cognitive biotype of depressionLaura M Hack, Jenna Jubeir, Rachel Hilton, et al.
Comprehensive Psychoneuroendocrinology|June 27, 2022
Epigenetic prediction of 17β-estradiol and relationship to trauma-related outcomes in womenLaura M Hack, Shota Nishitani, Anna K Knight, et al.
Journal of Affective Disorders|February 26, 2019
Moving pharmacoepigenetics tools for depression toward clinical useLaura M Hack, Gabriel R Fries, Harris A Eyre, et al.
Nature. Mental Health|January 8, 2024
Randomized trial of ketamine masked by surgical anesthesia in patients with depressionTheresa R Lii, Ashleigh E Smith, Josephine R Flohr, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Environmental Epigenetics|March 2, 2018
Epigenetic mechanisms involved in the effects of stress exposure: focus on 5-hydroxymethylcytosineLaura M Hack, Alec L W Dick, Nadine Provençal
Drugs in Context|February 16, 2018
Practical outpatient pharmacotherapy for alcohol use disorderYoungjung Kim, Laura M Hack, Elizabeth S Ahn, et al.
A&A Practice|August 11, 2022
Anesthetic-Induced Intraoperative Dream Associated With Remission of a Psychiatric Disorder: A Case ReportHarrison S Chow, Laura M Hack, Makoto Kawai, et al.
Journal of Affective Disorders|April 4, 2025
Opioids diminish the placebo antidepressant response: Observational post hoc findings from a randomized controlled ketamine trialTheresa R Lii, Josephine R Flohr, Robin L Okada, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Opioids Diminish the Placebo Antidepressant Response: A Post Hoc Analysis of a Randomized Controlled Ketamine TrialTheresa R Lii, Josephine R Flohr, Robin L Okada, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 24, 2020
Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trialAdina S Fischer, Bailey Holt-Gosselin, Scott L Fleming, et al.
Nature. Mental Health|November 10, 2025
A stratified precision medicine trial targeting α<sub>2A</sub>-adrenergic receptor agonism as a treatment for the cognitive biotype of depressionLaura M Hack, Jenna Jubeir, Rachel Hilton, et al.
Comprehensive Psychoneuroendocrinology|June 27, 2022
Epigenetic prediction of 17β-estradiol and relationship to trauma-related outcomes in womenLaura M Hack, Shota Nishitani, Anna K Knight, et al.
Journal of Affective Disorders|February 26, 2019
Moving pharmacoepigenetics tools for depression toward clinical useLaura M Hack, Gabriel R Fries, Harris A Eyre, et al.
Nature. Mental Health|January 8, 2024
Randomized trial of ketamine masked by surgical anesthesia in patients with depressionTheresa R Lii, Ashleigh E Smith, Josephine R Flohr, et al.
Pageof 3